78 related articles for article (PubMed ID: 25311090)
1. Vigabatrin pediatric dosing information for refractory complex partial seizures: results from a population dose-response analysis.
Nielsen JC; Tolbert D; Patel M; Kowalski KG; Wesche DL
Epilepsia; 2014 Dec; 55(12):e134-8. PubMed ID: 25311090
[TBL] [Abstract][Full Text] [Related]
2. Population dose-response analysis of daily seizure count following vigabatrin therapy in adult and pediatric patients with refractory complex partial seizures.
Nielsen JC; Hutmacher MM; Wesche DL; Tolbert D; Patel M; Kowalski KG
J Clin Pharmacol; 2015 Jan; 55(1):81-92. PubMed ID: 25117853
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
Bruni J; Guberman A; Vachon L; Desforges C
Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
[TBL] [Abstract][Full Text] [Related]
4. Dose-response study of vigabatrin in children with refractory epilepsy.
Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
[TBL] [Abstract][Full Text] [Related]
5. Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.
Pellock JM; Faught E; Foroozan R; Sergott RC; Shields WD; Ziemann A; Lee D; Dribinsky Y; Torri S; Othman F; Isojarvi J
Epilepsy Behav; 2016 Jul; 60():174-180. PubMed ID: 27208827
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.
Faught E
Acta Neurol Scand Suppl; 2011; (192):29-35. PubMed ID: 22061178
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of the effectiveness and safety of vigabatrin].
Jedrzejczak J; Owczarek K
Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
[TBL] [Abstract][Full Text] [Related]
8. Balancing clinical benefits of vigabatrin with its associated risk of vision loss.
Pellock JM
Acta Neurol Scand Suppl; 2011; (192):83-91. PubMed ID: 22061183
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.
Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD
Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin therapy for refractory complex partial seizures: review of major European trials.
Ben-Menachem E; Sander JW
Acta Neurol Scand Suppl; 2011; (192):16-28. PubMed ID: 22061177
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin in pediatric patients with refractory epilepsy.
Turanli G; Celebi A; Yalnizoğlu D; Topçu M; Topaloğlu H; Banu A; Aysun S
Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic evaluation of vigabatrin dose for the treatment of refractory focal seizures in children using adult and pediatric data.
Rodrigues C; Chiron C; Ounissi M; Dulac O; Gaillard S; Nabbout R; Jullien V
Epilepsy Res; 2019 Feb; 150():38-45. PubMed ID: 30639958
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin.
Connelly JF
Ann Pharmacother; 1993 Feb; 27(2):197-204. PubMed ID: 8439699
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
Friedman D; Bogner M; Parker-Menzer K; Devinsky O
Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.
French JA; Mosier M; Walker S; Sommerville K; Sussman N
Neurology; 1996 Jan; 46(1):54-61. PubMed ID: 8559421
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.
Tolman JA; Faulkner MA
Expert Opin Pharmacother; 2009 Dec; 10(18):3077-89. PubMed ID: 19954276
[TBL] [Abstract][Full Text] [Related]
17. Visual field constriction is not limited to children treated with vigabatrin.
Wohlrab G; Boltshauser E; Schmitt B; Schriever S; Landau K
Neuropediatrics; 1999 Jun; 30(3):130-2. PubMed ID: 10480207
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
Pfersmann D; Saletu B; Semlitsch HV; Anderer P; Dieterich HA
Wien Med Wochenschr; 1993; 143(6):119-28. PubMed ID: 8517061
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics analysis of vigabatrin in adults and children with epilepsy and children with infantile spasms.
Nielsen JC; Kowalski KG; Karim A; Patel M; Wesche DL; Tolbert D
Clin Pharmacokinet; 2014 Nov; 53(11):1019-31. PubMed ID: 25172554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
